What Liquid Biopsy Is
Liquid biopsy is a diagnostic technique that involves analyzing circulating tumor DNA (ctDNA) found in the bloodstream. This method allows for non-invasive monitoring of cancer, providing valuable information about the genetic makeup of tumors without the need for invasive tissue sampling.
The primary advantage of liquid biopsy is its ability to detect minimal residual disease and monitor treatment response over time, making it a crucial tool in precision medicine.
How It Works
Circulating tumor DNA refers to small fragments of genetic material released by dying cancer cells into the bloodstream. These ctDNA molecules carry the same mutations as the primary tumor and can be detected using advanced sequencing technologies.
The process involves collecting a blood sample, isolating ctDNA from plasma, and then analyzing it for specific genetic alterations associated with the patient’s cancer type.
Why It Matters
Liquid biopsy is significant because it offers a less invasive alternative to traditional tissue biopsies. This non-invasive approach can be performed repeatedly, allowing clinicians to monitor disease progression and treatment efficacy more frequently without additional stress on the patient.
Moreover, liquid biopsy can detect ctDNA at very low levels, making it highly sensitive for early detection of cancer recurrence or minimal residual disease.
Real-World Examples
In clinical practice, liquid biopsy has been used to identify specific mutations that guide targeted therapy decisions. For example, in non-small cell lung cancer (NSCLC), the detection of EGFR mutations can determine whether a patient is eligible for EGFR-targeted drugs.
Additionally, liquid biopsy can help monitor response to immunotherapy by detecting changes in ctDNA levels over time, providing insights into the effectiveness of treatment.
Frequently asked questions
How accurate is liquid biopsy compared to traditional tissue biopsies?
While highly sensitive and non-invasive, liquid biopsy may not always provide as much information as a tissue biopsy. However, it can be more accurate for detecting certain mutations and monitoring treatment response over time.
Can liquid biopsy detect all types of cancer?
Liquid biopsy is particularly effective for cancers that release ctDNA into the bloodstream, such as lung, colorectal, and breast cancer. Its effectiveness varies by cancer type and stage.
Is liquid biopsy painful or risky for patients?
No, liquid biopsy involves a simple blood draw, which is minimally invasive and poses minimal risk to the patient compared to traditional biopsies that require tissue sampling.
How long does it take to get results from a liquid biopsy test?
The time required for results can vary depending on the laboratory and testing method used, but it typically takes several days to weeks. Some newer technologies are aiming to reduce this timeframe significantly.
Try it live
Everything above runs in your browser — open Liquid Biopsy ctDNA Detection and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.
▶ Open Liquid Biopsy ctDNA Detection simulation